Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of CorMedix Inc (NASDAQ: CRMD) closed at $8.10 in the last session, up 0.25% from day before closing price of $8.08. In other words, the price has increased by $0.25 from its previous closing price. On the day, 0.64 million shares were traded. CRMD stock price reached its highest trading level at $8.1599 during the session, while it also had its lowest trading level at $7.9.
Ratios:
We take a closer look at CRMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.43 and its Current Ratio is at 4.79. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 26, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.Needham initiated its Buy rating on February 17, 2021, with a $31 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 13 ’24 when Todisco Joseph bought 13,561 shares for $3.74 per share. The transaction valued at 50,718 led to the insider holds 352,839 shares of the business.
DUNTON ALAN W bought 3,000 shares of CRMD for $10,350 on Dec 14 ’23. The Director now owns 12,250 shares after completing the transaction at $3.45 per share. On Dec 15 ’23, another insider, DUNTON ALAN W, who serves as the Director of the company, bought 3,000 shares for $3.30 each. As a result, the insider paid 9,900 and bolstered with 15,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 452466016 and an Enterprise Value of 407449920. For the stock, the TTM Price-to-Sale (P/S) ratio is 558.60 while its Price-to-Book (P/B) ratio in mrq is 9.69. Its current Enterprise Value per Revenue stands at 505.446 whereas that against EBITDA is -7.024.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $8.43, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 43.11%, while the 200-Day Moving Average is calculated to be 75.86%.
Shares Statistics:
According to the various share statistics, CRMD traded on average about 741.68K shares per day over the past 3-months and 958380 shares per day over the past 10 days. A total of 54.94M shares are outstanding, with a floating share count of 54.85M. Insiders hold about 1.81% of the company’s shares, while institutions hold 30.54% stake in the company. Shares short for CRMD as of 1726185600 were 10381716 with a Short Ratio of 14.00, compared to 1723680000 on 10317339. Therefore, it implies a Short% of Shares Outstanding of 10381716 and a Short% of Float of 18.59.
